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Abstract
CD4
+CD25
+Foxp3
+ regulatory T cells (Tregs) regulate disease-associated immunity and excessive inflammatory responses,
and numbers of CD4
+CD25
+Foxp3
+ Tregs are increased during malaria infection. The mechanisms governing their
generation, however, remain to be elucidated. In this study we investigated the role of commonly accepted factors for
Foxp3 induction, TCR stimulation and cytokines such as IL-2, TGFb and IL-10, in the generation of human CD4
+CD25
+Foxp3
+
T cells by the malaria parasite Plasmodium falciparum. Using a co-culture system of malaria-infected red blood cells (iRBCs)
and peripheral blood mononuclear cells from healthy individuals, we found that two populations of Foxp3
hi and Foxp3
int
CD4
+CD25
hi T cells with a typical Treg phenotype (CTLA-4
+, CD127
low, CD39
+, ICOS
+, TNFRII
+) were induced. Pro-
inflammatory cytokine production was confined to the Foxp3
int subset (IFNc, IL-4 and IL-17) and inversely correlated with
high relative levels of Foxp3
hi cells, consistent with Foxp3
hi CD4 T cell–mediated inhibition of parasite-induced effector
cytokine T cell responses. Both Foxp3
hi and Foxp3
int cells were derived primarily from proliferating CD4
+CD25
2 T cells with a
further significant contribution from CD25
+Foxp3
+ natural Treg cells to the generation of the Foxp3
hi subset. Generation of
Foxp3
hi, but not Foxp3
int, cells specifically required TGFb1 and IL-10. Add-back experiments showed that monocytes
expressing increased levels of co-stimulatory molecules were sufficient for iRBC-mediated induction of Foxp3 in CD4 T cells.
Foxp3 induction was driven by IL-2 from CD4 T cells stimulated in an MHC class II–dependent manner. However, transwell
separation experiments showed that direct contact of monocytes with the cells that acquire Foxp3 expression was not
required. This novel TCR-independent and therefore antigen-non specific mechanism for by-stander CD4
+CD25
hiFoxp3
+ cell
induction is likely to reflect a process also occurring in vivo as a consequence of immune activation during malaria infection,
and potentially a range of other infectious diseases.
Citation: Scholzen A, Mittag D, Rogerson SJ, Cooke BM, Plebanski M (2009) Plasmodium falciparum–Mediated Induction of Human CD25
hiFoxp3
hi CD4 T Cells Is
Independent of Direct TCR Stimulation and Requires IL-2, IL-10 and TGFb. PLoS Pathog 5(8): e1000543. doi:10.1371/journal.ppat.1000543
Editor: James W. Kazura, Case Western Reserve University, United States of America
Received March 4, 2009; Accepted July 16, 2009; Published August 14, 2009
Copyright:  2009 Scholzen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Australian NHMRC (BMC, SJR and MP) and the Howard Hughes Medical Institute International Scholar’s Program
(support to MP). AS was a recipient of an Endeavour International Postgraduate Research Scholarship and a Melbourne International Research Scholarship at the
University of Melbourne, Department of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Anja.Scholzen@med.monash.edu.au (AS); Magdalena.Plebanski@med.monash.edu.au (MP)
Introduction
Malaria is one of the most important infectious diseases in humans,
affecting 300–600 million people annually with more than a million
fatal cases per year [1]. Infection with the Plasmodium parasite occurs
hand in hand with a disturbance of immune homeostasis. While
malaria is associated with severe immune-mediated pathology due to
excessive inflammatory responses to the erythrocytic stage of the
parasite [2], impaired T cell responses are also a hallmark of acute
malaria infection [3–7]. CD4
+CD25
+Foxp3
+ regulatory T cells
(Tregs) are important players in maintaining immune homeostasis
and controlling excessive immune responses [8], and disproportion-
ate induction or expansion of Tregs may also explain the
immunosuppressive state during acute malaria infection [9]. Indeed,
while functions attributed to these cells differ greatly depending
on the experimental model used, increased numbers of
CD4
+CD25
+Foxp3
+ T cells have been found in both human [10–
13] and murine [14–18] malaria infection. Increased levels of
CD4
+CD25
+Foxp3
+ T cells can result either from the expansion of
thymic-derived natural Tregs or from the de novo induction from
previously naı ¨ve T cells. The de novo induction of the Treg-associated
transcription factor Foxp3 in naı ¨ve human CD4 T cells has to date
mainlybeen examined in in vitro systems using artificial stimuli such as
TCR ligation via anti-CD3 in the presence of exogenously added
recombinant cytokines including IL-2 and TGFb [19,20]. The
mechanisms of Treg induction by the malaria parasite, however, and
thepotentialcontributionoftheabovefactors(TCRstimulation,IL-2
and TGFb) remain unknown.
TGFb as well as IL-10 are functional mediators of immuno-
suppression [20–25] and have additionally been shown to play an
important role in controlling excessive immune responses during
malaria infection [15,26–32]. Moreover, production of IL-10
during the early acute phase of infection is associated with an
increased proportion of splenic CD4
+CD25
+ T cells in non-lethal
P. yoelii infection [28]. In humans, an early peak of bioactive serum
TGFb precedes the up-regulation of CD4
+CD25
+ T cells and
PLoS Pathogens | www.plospathogens.org 1 August 2009 | Volume 5 | Issue 8 | e1000543Foxp3 mRNA levels in whole peripheral blood mononuclear cells
(PBMCs) [11]. While these studies suggest the involvement of IL-
10 and TGFb in CD4
+CD25
+ Treg induction during malaria, no
causal connection has been proven to date. Studies on human
subjects often only allow looking at Treg numbers and cytokine
levels at limited time points after infection and more importantly
do not allow any intervention. Therefore, in vitro assays reflecting in
vivo processes as closely as possible are needed to examine the
mechanisms involved in the malaria parasite-mediated generation
of CD4
+CD25
+Foxp3
+ human T cells.
In this study, we have examined the contribution of monocyte-
mediated TCR stimulation and cytokines including IL-2, IL-10
and TGFb to the induction of CD4
+CD25
+Foxp3
+ T cells using
an in vitro co-culture system of trophozoite-stage malaria-infected
red blood cells (iRBC) with PBMCs from healthy donors in the
absence of any further stimulation or addition of exogenous
cytokines. We found that iRBCs, at concentrations typically found
during mild/uncomplicated human malaria infection [12,13],
dose-dependently induce two populations of CD4
+CD25
hi T cells,
which express Foxp3 at high or intermediate levels and have
distinct cell-contact and cytokine requirements for their induction.
High ratios of Foxp3
hi:Foxp3
int cells inversely correlated with the
magnitude of effector cytokine production by Foxp3
int cells,
consistent with suppressive activity of parasite-induced Foxp3
hi
cells on concomitantly induced effector Foxp3
int cells. The specific
dependence of iRBC-induced CD4
+CD25
hiFoxp3
hi T cells on IL-
10 and TGFb demonstrated here further highlights the impor-
tance of these immuno regulatory cytokines during malaria
infection. Importantly, direct monocyte contact was only required
with bystander CD4
+ T cells for the generation of soluble
mediators, but not with the future Foxp3 expressing T cells
themselves. These findings have implications beyond malaria
infection, as they demonstrate that Foxp3 induction, contrary to
current belief, is not necessarily confined to cells subjected to direct
antigen-presenting cell (APC) mediated TCR stimulation.
Results
Time- and concentration-dependent induction of
CD25
hiFoxp3
hi and Foxp3
int CD4 T cells by malaria-iRBCs
We first asked whether Foxp3 expressing CD4 T cells could be
induced by culturing PBMCs of healthy Australian blood bank
donors with malaria-infected trophozoite stage RBCs (iRBCs).
Indeed, we observed an enhanced proportion of CD25
hiFoxp3
+
CD4 T cells, when PBMC were cultured in the presence of iRBCs
but not normal RBCs (nRBC) for 6 days (Figure 1A). Within the
CD25
hi gate, two populations could be distinguished based on
their Foxp3 expression levels (Figure 1A). The existence of the two
populations was further confirmed with a second anti-Foxp3 mAb
(clone 259D, data not shown). While isotype/background staining
was elevated on all CD25
+ CD4 T cells in day 6 cultures, specific
Foxp3 staining was only observed in the CD25
+/hi population
(Figure 1B). There was no significant difference in the proportion
of CD4
+ T cells and the absolute number of CD4
+CD25
2Foxp3
2
T cells recovered from PBMC cultured without RBCs or with
nRBCs compared to iRBCs (Figure 1C), showing that the increase
in Foxp3 expressing cells in iRBC:PBMC co-cultures was not due
to a loss of the CD25
2Foxp3
2 population. The higher recovery in
absolute numbers of CD4
+ T cells from iRBC:PBMC co-cultures
was due to the appearance of the CD25
hiFoxp3
int and CD25
hi-
Foxp3
hi populations (Figure 1C). For all further analysis,
CD25
hiFoxp3
int and CD25
hiFoxp3
hi cells were analysed as the
percentage of CD4 T cells, unless stated otherwise.
The percentage of induced CD25
hiFoxp3
hi and CD25
hiFoxp3
int
CD4 T cells was dependent on the amount of iRBC added to the
culture and increased with rising iRBC:PBMC ratios (Figure 1D;
P,0.0001, one-way ANOVA with linear trend post-test). The
ratios used were calculated to reflect a range of natural
concentrations typically found in the peripheral blood of
malaria-infected individuals with low to medium parasitemia
[12,13] (0.001 to 0.1% parasitemia). Induction of CD25
hiFoxp3
hi
and CD25
hiFoxp3
int CD4 T cells was detectable after 3–4 days of
exposing PBMCs to iRBCs, and CD25
hiFoxp3
int CD4 T cells
were generally detectable 24 h earlier than the CD25
hiFoxp3
hi
population in 5 out of 7 donors examined (Figure 1E). Overall
levels of Foxp3 expressing cells increased until day 6 of iRBC co-
culture (Figure 1E), and were stable up to day 8 (3 out of 3 donors,
data not shown). In co-cultures with nRBCs or in the absence of
RBCs, CD25 and Foxp3 expression levels remained unchanged
throughout the whole culture period (Figure 1E and data not
shown) and were similar to those on freshly isolated CD4 T cells
(Figure 2B). Unless otherwise stated, day 6 was used as the time
point for analysis in subsequent experiments.
iRBC-induced CD25
hiFoxp3
hi and Foxp3
int CD4 T cells
have a typical Treg phenotype
Specific Foxp3 expression in the induced CD25
hi CD4 T cells
compared to CD4
+CD25
2 cells (P=0.002) was further confirmed
by quantitative real-time PCR analysis of MACS-sorted
CD4
+CD25
2 and CD25
hi T cells. Additionally, iRBC-induced
CD4
+CD25
hiFoxp3
+ T cells also contained higher mRNA levels of
the immunosuppressive cytokines IL-10 (P=0.04) and TGFb1
(P=0.002) than CD25
2Foxp3
2 CD4 T cells (Figure 2A).
Phenotyping of the CD25
hiFoxp3
hi and Foxp3
int populations on
day 6 of co-culture (2:1 iRBC:PBMC ratio) showed a largely
similar phenotype compared with conventional natural
CD25
+Foxp3
+ Tregs (nTregs) in freshly isolated PBMCs (on day
0). All three populations expressed reduced levels of CD127 (IL-
7Ralpha) and CCR7, and enhanced levels of CTLA-4, CD122 (IL-
2Rbeta), CD45RO, HLA DR and CD39 compared to
Author Summary
Infection with the malaria parasite Plasmodium falciparum
affects 300–600 million people each year. Regulatory T
cells (Tregs) expressing the transcription factor Foxp3,
which drives genes involved in immunosuppression, are
specialized immune cells that can inhibit both protective
and harmful inflammatory responses during malaria. While
Treg numbers are increased during malaria infection, little
is known about how they are induced by the parasite. We
addressed this question using an in vitro culture system to
model the interaction of the malaria parasite with human
immune cells. We found that the parasite induced soluble
immune mediators, including the T cell growth-factor IL-2
and the regulatory proteins IL-10 and TGFb, which drive
the induction and expansion of Tregs. These Tregs
expressed high levels of Foxp3 and suppressed the
production of inflammation and protective immunity-
driving mediators by concurrently induced effector T cells.
Importantly, we demonstrate that induction of Tregs by
the malaria parasite did not necessarily require direct
contact with antigen-presenting cells. Our findings sug-
gest that the parasite induces Tregs in an antigen non-
specific manner, which may explain why malarial immu-
nosuppression is not confined to malaria-specific immune
responses, and provide new insights into the mechanisms
governing Treg induction during malaria infection, and
potentially other infectious diseases.
Foxp3 Induction in Malaria
PLoS Pathogens | www.plospathogens.org 2 August 2009 | Volume 5 | Issue 8 | e1000543Figure 1. Induction of Foxp3
hi and Foxp3
int CD4
+CD25
hi T cells by malaria-infected RBCs is time and concentration-dependent.
PBMC were cultured alone, with uninfected RBCs (nRBC) or iRBCs for 6 days at different iRBC:PBMC ratios. Cells were analysed by flow cytometry for
CD25 and Foxp3 expression in gated CD4
+CD3
+ lymphocytes. Dot plots show 1 representative of 12 donors examined (A). Comparative analysis of
Foxp3 and isotype control staining on CD4
+CD25
2 T cells and CD4
+CD25
+ T cells in day 6 cultures revealed specific Foxp3 expression solely in the
CD25
+ population (B). Absolute numbers of different CD4 T cell populations for 4 donors (Mean+/2SEM) were calculated based on light microscopic
cell counts and flow cytometry analysis on day 6 of culture of originally 2610
7 PBMCs co-cultured in the absence or presence of nRBCs and iRBCs (C).
Data from 12 donors demonstrate iRBC concentration-dependent induction of Foxp3
hi and Foxp3
int CD4
+CD25
hi T cells (D). A representative plot of 1
out of 7 donors shows the induction of these cells over a time course of 6 days (E).
doi:10.1371/journal.ppat.1000543.g001
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PLoS Pathogens | www.plospathogens.org 3 August 2009 | Volume 5 | Issue 8 | e1000543Figure 2. Phenotype of Foxp3
hi and Foxp3
int CD4
+CD25
hi T cells induced by malaria-infected RBCs. After 8 days of iRBC:PBMC co-culture,
immuno magnetic selection was used to isolate CD4
+CD25
hi (black line) and CD25
2 cells (grey filled). CD25 and Foxp3 expression in the two sorted
populations was analysed by flow cytometry (A). mRNA levels for Foxp3, TGFb1 and IL-10 were normalized on 18SrRNA levels for each donor. Data from 8
donors (Mean+/2SEM) are shown, presented as relative mRNA levels normalized on mRNA levels in CD4
+CD25
2 T cells for each donor (A). PBMC of 3 donors
were phenotyped on day 0 prior to iRBC-PBMC co-culture set up, and after 6 days of iRBC:PBMC co-culture (2:1 ratio). Dot plots show the gating strategiesf o r
Foxp3 expressing cells on day 0 and day 6, respectively (B). Representative histograms depicting isotype control staining (grey filled) and specifics t a i n i n gf o r
various surface markers on CD25
2Foxp3
2 and CD25
hi Foxp3-expressing CD4 T cells (black line) from each respective culture are shown (B).
doi:10.1371/journal.ppat.1000543.g002
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+CD25
2 T cells in the same culture (Figure 2B). Interestingly,
molecules associated with inhibitory function of nTregs in the
literature such as CD39 and CTLA-4 were expressed at higher
levels on these iRBC-induced Foxp3
+ cells compared to nTregs.
Additionally, induced day 6 Foxp3
hi and Foxp3
int CD4
+CD25
hi T
cells, but not day 0 nTregs, expressed high levels of ICAM-1,
indicating recent activation. None of these markers did, however,
help to distinguish between the CD25
hiFoxp3
hi and CD25
hiFox-
p3
int cells. Two additional recently identified Treg-associated
markers, ICOS [33–35] and TNFRII [36], were found in high
level on induced Foxp3
hi and Foxp3
int cells. Expression of both
molecules was slightly elevated on Foxp3
hi compared to Foxp3
int
CD4
+CD25
hi T cells, but both markers were equally unsuitable to
purify the Foxp3
hi subset to analyse its suppressive capacity, as
they did not distinguish clearly separate populations between the
two subsets (Figure 2B).
Th effector cytokine production by iRBC-induced
Foxp3
int CD4 T cells is negatively affected by high ratios
of Foxp3
hi:Foxp3
int cells
To nevertheless determine whether Foxp3
hi and Foxp3
int
CD4
+CD25
hi T cells might differ functionally, cells were re-
stimulated with PMA/ionomycin on day 6 of iRBC:PBMC co-
culture and examined for production of the pro-inflammatory T
helper (Th) effector cytokines IFNc, IL-4 and IL-17 as well as the
T cell proliferation and survival factor IL-2 (Figure 3A). IL-2 was
produced in similar amounts by both CD25
2Foxp3
2 and
CD25
hiFoxp3
int CD4 T cells (P.0.05), but not by CD25
hiFoxp3
hi
cells (P,0.05 compared to CD25
2Foxp3
2 and CD25
hiFoxp3
int
cells, one-way ANOVA with Neuman-Keuls’ post-test). In
contrast, the predominant Th effector cytokine producing cells
in these cultures were the Foxp3
int population (P,0.001 for IL-17,
P,0.01 for IL-4 and P,0.05 for IFNc compared to
CD25
2Foxp3
2 cells, and P,0.001 for IL-17, IL-4 and IFNc
compared to CD25
hiFoxp3
hi cells, one-way ANOVA with Neu-
man-Keuls’ post-test), indicating that these cells may constitute
activated effector T cells. Finally, within the Foxp3
hi subset over
99% of cells did not produce any Th effector cytokines, which is
consistent with the properties of Tregs.
We further utilized the combination of intracellular Foxp3 and
Th effector cytokine staining as a means to gain insight into the
potential suppressive activity of the Foxp3
hi population, whilst
avoiding the necessity to purify the different subsets (which is not
possible due to the lack of suitable surface markers to differentiate
between the otherwise intracellularly stained Foxp3
hi and effector-
like Foxp3
int cells). Specifically, we asked whether changes in the
relative proportion of induced Foxp3
hi to Foxp3
int cells would
affect the ability of the Foxp3
int population to produce Th effector
cytokines. We concentrated on the Th1 and Th2 effector cytokines
IFNc and IL-4, which play important roles in anti-malarial
immunity and immunopathology [37–40], as well as the Th17
cytokine IL-17, which promotes the recruitment of neutrophils
[41] that contribute to the clearance of malaria-infected RBCs as
well as malaria pathogenesis [42,43]. If the Foxp3
hi population
had indeed suppressive activity on the parasite-induced T effector
population, then the Foxp3
int population in donors with higher
ratios of Foxp3
hi:Foxp3
int cells would contain a smaller proportion
of Th effector cytokine-producing cells compared to donors with a
lower ratio of Foxp3
hi:Foxp3
int cells. Indeed, we found a strong
and significant inverse correlation between the Foxp3
hi:Foxp3
int
ratio and the proportion of cytokine-producing cells within the
Foxp3
int population (Figure 3B; Spearman rank correlation;
Rs=0.69, P=0.0014 for IFNc; Rs=0.69, P=0.0087 for IL-4;
Rs=0.62, P=0.048 for IL-17).
iRBC-induced Foxp3
+ CD4
+ T cells have proliferated and
are predominantly derived from the CD4
+CD25
2Foxp3
2
T cell population
We next tested whether iRBC-induced Foxp3
hi and Foxp3
int
cells were derived from proliferating CD4 T cells. PBMCs were
labelled with CFSE and analysed on day 6 for CFSE dilution and
Foxp3 expression within the CD4 T cell compartment (Figure 4A).
As shown in Figure 4B, 79+/24.1% of Foxp3
int and 82.2+/
23.4% of Foxp3
hi CD4 T cells (Mean+/2SEM) had proliferated
within the 6 days of iRBC co-culture. When examining CFSE
dilution and Foxp3 expression continuously over a time course of 6
days, we found that Foxp3 expression was initially up-regulated in
the absence of proliferation, followed by proliferation resulting in a
steady increase in both Foxp3
hi and Foxp3
int subsets (Figure 4C).
We next investigated whether the two Foxp3
+ populations could
be induced from CD25
2 CD4 T cells, and whether there was a
contribution from potentially expanding CD25
+Foxp3
+ CD4
nTregs present in the initial PBMC population. To answer this
question, PBMCs were depleted of CD25
+ cells prior to onset of
the iRBC:PBMC co-culture, with an average depletion efficiency
of CD25
+Foxp3
+ nTregs by 93.8+/22% (Mean+/2SEM)
(Figure 4D). As shown in Figure 4E, CD25
hiFoxp3
hi and
CD25
hiFoxp3
int were induced from both whole and CD25
depleted PBMC with similar kinetics. However, we found that in
11/15 donors, CD25 depletion prior to onset of iRBC:PBMC co-
culture led to a significant decrease (ranging from 6–72%,
Figure 4F and data not shown) in the bulk iRBC-induced CD25
hi
population compared to undepleted PBMC:iRBC co-cultures. To
determine the proportions of iRBC-induced Foxp3
hi or Foxp3
int
cells from whole versus CD25 depleted PBMCs independent of the
confounding influence of CD25 depletion on the total proportion
of the induced CD4
+CD25
hi T cells, we thus analyzed the
percentage of Foxp3
hi and Foxp3
int cells within the CD25
hi
compartment rather than within the complete CD4 T cell
population. We found that overall there was a significant reduction
in the iRBC-induced proportion of Foxp3
hi cells within the
CD4
+CD25
+ T cell population in iRBC co-cultures with CD25
depleted PBMCs (Median 6.2%; interquartile range 2.3–10.2)
compared to whole PBMCs (Median 7.3%; interquartile range
6.1–12.1; P=0.015, Figure 4G). The induction of Foxp3
int cells, in
contrast, was largely unaffected (Median 93.8% (interquartile
range 89.8–97.7) from whole PBMCs compared to 92.7%
(interquartile range 87.9–93.9) from CD25 depleted PBMCs).
This indicates that the virtually all CD4
+CD25
hiFoxp3
int cells and
the majority of CD4
+CD25
hiFoxp3
hi cells were derived from
CD4
+CD25
2 non Tregs. However, CD25
+Foxp3
+ nTregs
additionally contributed to the induction of CD4
+CD25
hiFoxp3
hi
cells in iRBC:PBMC co-cultures.
Monocytes expressing increased levels of co-stimulatory
molecules are sufficient for iRBC-mediated induction of
Foxp3 expression
Foxp3 expression in CD4 T cells was not induced when purified
T cells as opposed to whole PBMCs were co-cultured with iRBCs,
demonstrating that induction of Foxp3
+ CD4 T cells is not due to
a direct interaction of T cells with iRBCs but dependent on other
cells present in the co-culture system (Figure 5A). APCs have been
suggested to play a fundamental role in the induction of Tregs
[44], and monocytes are the most abundant APCs in human
peripheral blood. To evaluate the possibility that monocytes
interacting with iRBCs were responsible for the induction of
Foxp3
+ CD4 T cells, we co-cultured purified T cells with positively
selected CD14
+ monocytes at ratios consistent with the original
Foxp3 Induction in Malaria
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for each donor. As shown in Figure 5A, CD14
+ monocytes were
sufficient to induce CD25
hiFoxp3
hi and CD25
hiFoxp3
int CD4 T
cells. The levels of the two subsets induced were further similar to
those observed when adding back all non-T cells including both
monocytes and other PBMCs such as NK cells and B cells
(obtained from negative T cell isolation). This demonstrates that
the additional presence of other PBMCs did not have an additive
effect on the levels of induced Foxp3
int or Foxp3
hi cells.
Monocytes further required direct contact with T cells to induce
both CD25
hiFoxp3
hi and CD25
hiFoxp3
int CD4 T cells, as
separation of T cells and monocytes through a transwell abrogated
Figure 3. CD4
+CD25
hiFoxp3
hi T cells do not produce effector cytokines and high Foxp3
hi:Foxp3
int ratios inversely correlate with Th
effector cytokine production by Foxp3
int cells. On day 6 of culture at an iRBC:PBMC ratio of 1:5, cells were re-stimulated for 5 hours with PMA
and ionomycin, in the presence of brefeldin A for the last 4 hours. Surface marker and Foxp3 expression as well as cytokine production were analysed
by flow cytometry. (A) Bar graphs show the percentage of IFNc, IL-4, IL-17 and IL-2 producing cells within CD4
+CD25
2Foxp3
2, Foxp3
int and Foxp3
hi
CD4
+CD25
hi T cells as Mean+/2SEM for all donors examined (n=18 for IFNc, n=13 for IL-4, n=11 for IL-17 and n=5 for IL-2). Representative
histogram plots show anti-cytokine staining (black line) versus isotype/background staining (grey filled) within each of the three gated populations.
The percentage of cytokine positive cells within each gated population was determined using histogram plots as shown. (B) The relationship
between Foxp3
hi:Foxp3
int ratios and the percentage of Th effector cytokine (IFNc, IL-4, IL-17) producing cells within the CD25
hiFoxp3
int population
was examined using Spearman rank correlation.
doi:10.1371/journal.ppat.1000543.g003
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hi and Foxp3
int CD4
+CD25
hi T cells from CD4
+CD25
2 and CD25
+ T cells. PBMC werestained
withCFSE prior to set up of iRBC:PBMC co-cultures and analysed on day 6 (A). Data for dividing and non-dividing CD4
+ T cells were analysed as percentage
of total Foxp3
hi and Foxp3
int CD4
+ T cells from 7 donors (Mean+/2SEM) (B). Representative FACS plots for 1 out of 3 donors show the development of
Foxp3 expression and CFSE dilution over a time course of 6 days of iRBC co-culture (C) To determine the origin of Foxp3
hi and Foxp3
int CD4
+CD25
hi T cells,
PBMC were depleted from CD25
+ cells prior to set up with iRBCs. A representative dot plot demonstrating depletion efficiency of the CD25
+Foxp3
+ nTreg
population is shown (D). Cells were then analysed over a time course (day 3 to 6) for the kinetics of CD25 and Foxp3 induction by flow cytometry (E). A
representative dot plot for 1 out of 15 donors showing the generation of CD25
hiFoxp3
hi and CD25
hiFoxp3
int on day 6 is shown. Percentages of both
populations are expressed within total CD4 T cells (fine print) or within the CD25
hi population (bold print) (F). Due to a general decrease in the induction of
total CD25
hiCD4
+ cells from CD25 depleted versus whole PBMCs, Foxp3
hi or Foxp3
int induction was analysed as percentage within the CD25
hi CD4
population. Dataare represented as box-and-whisker-plots, withboxes extending from the25
th tothe 75
th percentile and horizontal lines representing the
median, while whiskers extend to the lowest and highest data point (G). Experiments were set up with an iRBC:PBMC ratio of 2:1.
doi:10.1371/journal.ppat.1000543.g004
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Neuman-Keuls’ post-test) (Figure 5B). When examining the
activation status of CD14
+ monocytes in iRBC:PBMC co-cultures,
we found that the levels of co-stimulatory molecules CD80, CD40
and CD86 were higher when iRBCs, but not nRBCs were added
to the co-culture (P,0.01, one-way ANOVA with Dunett’s post-
test; Figure 5D), suggesting strong T cell co-stimulatory capacity.
iRBC-mediated induction of CD80 and CD86, but not CD40 on
monocytes was further dose-dependent, with lower expression
levels at a 1:5 compared to a 2:1 iRBC:PBMC ratio.
iRBC-mediated induction of Foxp3 expression in
converting CD4
+ T cells requires MHC class II-induced
soluble factors but not direct contact with monocytes
A possible molecular basis for the dependency of Foxp3
induction on contact between T cells and monocytes could be
the interaction of monocyte-expressed MHC class II/peptide
complexes with the TCR of CD4
+ T cells. Indeed, blocking Abs
directed against HLA DR (clone L243) inhibited the induction of
Foxp3 expression (Figure 6A; P,0.001, one-way ANOVA with
Neuman-Keuls’ post-test). Blocking MHC class II-TCR interac-
tion additionally severely reduced day 2 IL-2 levels and day 6 IL-
10 levels in iRBC:PBMC co-culture supernatants (P,0.01)
(Figure 6B).
This raised the question whether the disruption of Foxp3
induction was due to the lack of MHC class II-induced soluble
factors such as IL-2 and IL-10 produced by intermediate/
bystander T cells, or to the lack of direct MHC class II interaction
with the converting T cells themselves. To test these two
possibilities, purified T cells were again separated from iRBC
co-cultured monocytes through a transwell. Surprisingly, induction
of CD25
hiFoxp3
hi and to a lesser degree also CD25
hiFoxp3
int
CD4
+ T cells outside the transwell could be partially restored
when iRBC co-cultured monocytes inside the transwell insert were
supplemented with T cells or replaced with iRBC co-cultured
PBMCs (containing both T cells and monocytes) (P,0.001, one-
way ANOVA with Neuman-Keuls’ post-test; Figure 7A and B).
There was no significant difference between the proportion of
induced CD25
hiFoxp3
hi and CD25
hiFoxp3
int cells whether
iRBC:monocyte:T cell co-cultures were set up inside or in the
absence of a transwell (Figure 7A and B). Interestingly,
Foxp3
hi:Foxp3
int ratios were significantly higher (P,0.05, one-
way ANOVA with Neuman-Keuls’ post-test) in CD4
+CD25
hi T
cells induced across the transwell in the absence of direct
Figure 5. Monocytes are sufficient for Foxp3 induction. To determine the cellular requirements for Foxp3 induction, purified T cells were
cultured with iRBCs alone or supplemented with donor-specific proportions of monocytes or all non-T cells and compared to iRBC co-cultured whole
PBMCs (A). To determine contact-dependency, T cells were separated from monocytes through a transwell (B). Bar graphs show data of 7 (A) or 9 (B)
donors (Mean+/2SEM) as relative proportions of CD25
hiFoxp3
hi or CD25
hiFoxp3
int cells. Fold changes were calculated by normalizing the percentage
of each of the two cell types of CD4
+ T cells for each donor on the percentage obtained for whole PBMC directly cultured with iRBCs (A) or direct
monocyte+T cell+iRBC co-cultures (B). Experiments were set up with an iRBC:PBMC ratio of 2:1 and similar results obtained for a 1:5 ratio. Levels of co-
stimulatory molecules CD80, CD40 and CD86 on CD14
+, CD3/19/56
2 PBMC were analysed after 2 days of nRBC or iRBC:PBMC culture as median
fluorescent intensities (MFIs). Data were normalized for each donor on MFIs obtained for PBMCs cultured with no RBCs and are shown as Mean+/
2SEM of 6–10 donors (C).
doi:10.1371/journal.ppat.1000543.g005
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cultures either inside or in the absence of a transwell (Figure 7C).
When examining the kinetics of CD25
hiFoxp3
hi and CD25
hiFox-
p3
int cell induction in direct and transwell separated cultures, we
found that whilst levels of CD25
hiFoxp3
hi cell increased up to day
6 in both culture conditions, the proportion of CD25
hiFoxp3
int
CD4 T cells stagnated from day 4 onwards (Figure 7D). Both IL-2
and IL-10 were only detectable in supernatants from cultures
where monocytes interacted with T cells (Figure 7D), consistent
with the requirement of MHC/TCR contact for their induction
(Figure 6B). This suggests that the direct interaction of iRBC-
treated monocytes with bystander T cells via MHC class II induces
soluble factors including IL-2 and IL-10, which in turn induce
Foxp3 expression in CD4
+ T cells that did not have direct contact
with monocytes themselves.
We further examined which particular population of bystander
T cells interacted with monocytes to promote the induction of
Foxp3 expression across the transwell. We addressed this question
by depleting purified T cells of anti-CD8, CD4 or CD25 single
stained cells via FACS sorting to leave the T cells, which interact
with the monocytes, untouched to avoid any possible interference
of surface antibodies on T cells with their function. Depleted T
cells were then added back to monocytes within the transwell at
the original ratios as determined in whole PBMCs for each donor.
As shown in Figure 7E, only CD8 depleted (i.e. CD4
+ T cells), but
not CD4 depleted (i.e. CD8
+ T cells) interacting with monocytes
within the transwell were capable of inducing Foxp3 expression
across the transwell. In line with this, only the interaction of CD8
depleted (CD4
+), but not CD4 depleted (CD8
+) T cells with
monocytes resulted in the secretion of IL-2 and IL-10 into the cell
culture supernatant (Figure 7E), consistent with MHC class II
dependency of these two cytokines as shown in Figure 6B.
Depletion of CD25
+ T cells did not decrease the induction of
Foxp3 expression across the transwell, suggesting that nTreg
interaction with monocytes is not required for Foxp3 induction on
separated CD4 T cells.
Finally, we asked whether CD25
hiFoxp3
hi and CD25
hiFoxp3
int
cells generated in the transwell system independent of direct TCR
stimulation displayed equivalent phenotypic and functional
characteristics to the Foxp3
hi and Foxp3
int cells generated in
direct iRBC:PBMC cultures. Similar to direct co-cultures, only
CD25
hiFoxp3
int but not CD25
hiFoxp3
hi cells contained a subset of
Th1 and Th2 cytokine producing cells (data not shown).
Moreover, transwell separated T cells showed both increased
Foxp3
hi:Foxp3
int ratios and a decreased proportion of IFNc and
IL-4 producing cells within the Foxp3
int subset compared to CD4
T cells in direct co-cultures (Figure 8A), which is consistent with
the results from the internal suppression assay shown in Figure 3B.
We further analyzed the phenotype of Foxp3
hi and Foxp3
int cells
induced in the direct co-culture or the transwell system and
compared their phenotype to CD25
+Foxp3
+ nTregs from freshly
isolated PBMCs prior to iRBC co-culture (Figure 8B). Induced
CD25
hiFoxp3
hi and CD25
hiFoxp3
int cells in both culture systems
had a very similar phenotype in regards to CD127, CD45RO and
CD39 expression. TNFRII, ICOS and CTLA-4 expression was
higher in Foxp3
hi compared to Foxp3
int cells in both direct and
transwell-separated cultures, however, overall expression levels of
these markers were 5–30 fold lower in Foxp3 expressing T cells
induced in transwell-separated compared to direct cultures and
more similar to day 0 nTregs.
iRBC induce a pro-inflammatory cytokine milieu in
combination with increased IL-10 and decreased TGFb1
levels
To further examine the role and nature of cytokines present in
the co-culture system contributing to the induction of Foxp3
Figure 6. Foxp3 induction is MHC class II-dependent. MHC class-II dependency was examined using 5 mg/ml neutralizing anti-HLA DR or
isotype control mAb. Cells were analysed for CD25 and Foxp3 expression on CD4 T cells on day 6 (A). Culture supernatants were sampled on day 2 (IL-
2) or day 6 (IL-10) for cytokine analysis by ELISA (B). Fold changes in the proportion of Foxp3
hi and Foxp3
int cells (black bars) were calculated by
normalizing for each donor the percentage of each of the two cell types of CD4
+ T cells or cytokine levels on the respective values obtained for
PBMCs cultured with iRBCs in the absence of any antibody (white bars). Experiments were set up with a 2:1 iRBC:PBMC ratio.
doi:10.1371/journal.ppat.1000543.g006
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monocytes with converting T cells. To determine contact-dependency for converting T cells, T cells were separated from iRBC-co-cultured whole
PBMC or T cells+monocytes through a 20 nm pore size transwell and analysed by flow cytometry on day 6. Bar graphs show data of 5 donors (Mean+/
2SEM), analysed as fold change in the induction of CD25
hiFoxp3
hi or CD25
hiFoxp3
int CD4 T cells (A). Representative FACS plots for each condition are
shown (B). Foxp3
hi:Foxp3
int ratios were calculated for T cells in direct co-cultures as well as inside and outside the transwell (C). Foxp3
hi and Foxp3
int
levels, as well as IL-2 and IL-10 levels in culture supernatants were monitored on day 2, 4, 5 and 6 and are shown for 1 out of 2 donors (D). To determine
which T cell subpopulation has to interact with monocytes to induce Foxp3 expression in transwell-separated T cells, T cells that were added back to
monocytes were depleted of CD4
+, CD8
+, or CD25
+ cells prior to culture. Proportions of CD25
hiFoxp3
hi andCD25
hiFoxp3
int cellsof CD4 T cells induced in
the transwell-separated T cell compartment (on day 6) as well as IL-2 and IL-10 levels in the culture supernatant (on day 2 and 6, respectively) were
measured and are shown as fold changes compared to whole T cells (E). Fold changes (black bars) were calculated by normalizing for each donor the
percentage of each of the two cell types of CD4
+ T cells or cytokine levels on the respective values obtainedfor monocytes+T cells directly cultured with
iRBCs (A)or for cultures with whole T cellsadded back to monocytes within the transwell (E) (white bars). TheT cell compartment analysed anddepicted
in each individual graph is highlighted in bold red. Experiments were set up with a 2:1 iRBC:PBMC ratio.
doi:10.1371/journal.ppat.1000543.g007
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hi and Foxp3
int T cells in direct co-cultures or separated through a transwell. T
cells from direct or transwell-separated iRBC co-cultures were harvested on day 6 of culture and either re-stimulated with PMA/ionomycin for intracellular
cytokine staining, or phenotyped directly. Foxp3
hi:Foxp3
int ratios and the percentage of IFNc or IL-4 producing cells within the CD25
hiFoxp3
int population
were determined for 5 donors. Values for transwell-separated T cells (black bars)are expressed as fold change following normalization onto values ind i r e c t
co-cultures(whitebars) foreachdonor(Mean+/2SEM) andcompared by paired Student’s t-test(A).Freshly isolatedCD25
2Foxp3
2 andCD25
+Foxp3
+CD4
+
T cells (day 0) and CD4
+CD25
2Foxp3
2,F o x p 3
int and Foxp3
hi CD4
+CD25
hi T cells from direct or transwell separated cultures (day 6) from 3 donors were
phenotypedforawiderangeofmarkers,andexpressionlevelsforeachsurfacemarkerwithineachpopulationwerenormalizedonisotypecontrolstaining,
when analysed as median fluorescence intensity (MFI). Expression levels of surface markers on CD4
+CD25
2Foxp3
2 cells were comparable between
conditions for each donor (data not shown). Thus, to compare the phenotype of day 0 CD25
+Foxp3
+ nTregs, and day 6 induced CD25
hiFoxp3
int and
CD25
hiFoxp3
hi cells (black bars), expression levels are expressed as fold change (Mean+/2SEM) compared to CD4
+CD25
2Foxp3
2 cells (white bars, relative
level=1) for each donor and condition (B). Experiments were set up with a 2:1 iRBC:PBMC ratio.
doi:10.1371/journal.ppat.1000543.g008
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profile. As shown in Figure 9A, the pro-inflammatory cytokines
IL-6 and IFNc and the anti-inflammatory cytokine IL-10 were
induced as early as 24 h after the addition of iRBCs and remained
at high levels throughout the duration of the co-culture. IL-2 levels
in the supernatant peaked at day 2–3 of co-culture and then
declined to barely detectable levels on day 5 and 6 (Figure 9A).
None of these cytokines were detectable in the absence of iRBCs.
High levels of total TGFb1 (latent plus bioactive) were
measured in the supernatant of untreated PBMCs on day 6 of
culture, ranging from 0.6–13.5 ng/ml (23 donors; Med-
ian=3.48 ng/ml; data not shown). Interestingly, day 6 TGFb1
levels were significantly decreased when PBMCs were co-cultured
with iRBCs (12 donors, P,0.01 for 2:1 ratio and P,0.05 for 1:5
ratio, one-way ANOVA with Neuman-Keuls’ post-test; Figure 9B),
but unchanged when PBMCs were co-cultured with uninfected
RBCs (15 donors, data not shown). This decrease in total TGFb1
was already evident and significant from 24 hours of co-culture
onwards (data not shown) and dependent on the amount of iRBCs
added to the co-culture (Figure 9B; P,0.0001, one-way ANOVA
with linear trend post-test). A decrease in total TGFb1 would be
consistent with either increased conversion into bioactive TGFb
and immediate consumption, or decreased production and
secretion. To test the latter, TGFb1 mRNA levels for 2 donors
were monitored over a time course of 6 days, showing no decrease
in TGFb1 mRNA in iRBC co-cultured PBMCs compared to
control cultures, but instead a 2–3 fold increase on day 5–6 of co-
culture (data not shown), suggesting a possible counter-regulatory
mechanism to enhanced TGFb consumption and therefore
decreasing TGFb protein levels in the cell culture supernatant.
We next tested whether the high baseline levels of TGFb1 in the
iRBC:PBMC co-cultures were due to autologous serum used to
supplement the co-culture medium, or produced endogenously by
cells within the co-culture system. While serum-supplemented
medium did contain high levels of TGFb1 before addition of cells
(day 0), TGFb1 levels increased over the first days of co-culture in
both serum-supplemented and serum-free cultures, and reached
comparable levels on day 6 of co-culture (Figure 9C). Further,
there was no significant difference in the proportion of
CD25
hiFoxp3
hi and CD25
hiFoxp3
int CD4
+ T cells on day 6 of
co-culture in serum-supplemented compared to serum-free
iRBC:PBMC co-cultures (Figure 9D), and no induction of these
cells was seen in the absence of iRBCs as expected (data not
shown). Foxp3 induction did therefore not depend on serum-
derived exogenous TGFb1, and TGFb1 was produced by cells in
the co-culture system.
To determine the cellular source of TGFb1 and IL-10 in
iRBC:PBMC co-cultures, individual cell populations were FACS-
sorted on day 6 and analysed for TGFb1 and IL-10 mRNA levels
expressed as normalized values compared to 18SrRNA, thus
reflecting the average mRNA levels on a per cell basis. Across 3
donors tested, monocytes and CD3
2CD56
+ NK cells produced
the highest amounts of TGFb1 mRNA (Figure 10A; P,0.05
according to one-way ANOVA with Neuman-Keuls’ post-test).
Monocytes (as well as CD4 T cells) were also the major source of
IL-10 mRNA (Figure 10A). Therefore, iRBC-exposed monocytes
had an alternatively activated phenotype with increased levels of
co-stimulatory molecules whilst at the same time producing
Figure 9. Cytokine levels in iRBC:PBMC co-culture supernatants. Co-culture supernatants were harvested and assayed at different time
points for IL-2, IFNc, IL-6 and IL-10. Histograms show absolute values in pg/ml (Mean+/2SEM) for 14–18 donors (A). Total TGFb1 levels in
supernatants of untreated or iRBC-treated PBMC were determined on day 6 of co-culture and are shown as fold change for 12 donors, normalized on
values from untreated PBMC (relative level=1) for each donor (B). The role of serum-derived TGFb1 for final TGFb1 levels in co-culture supernatants
was established in time course experiments for untreated (C) or iRBC-treated PBMC (data not shown) cultured in serum-supplemented or serum-free
AIM-V. A representative histogram for supernatant TGFb1 levels in pg/ml (Mean+/2StDev) for 1 out of 3 donors is shown (C). The proportions of
Foxp3
hi and Foxp3
int CD25
hi CD4
+ T cells in these cultures on day 6 were compared and are shown as Mean+/2SEM from 4 donors, normalized for
each donor on values in serum-free cultures (D).
doi:10.1371/journal.ppat.1000543.g009
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each population for the proportion of this population in whole
PBMCs (Figure 10B), however, CD4 T cells were the predominant
source of cellular TGFb1 and IL-10 mRNA in iRBC-treated
PBMCs, closely followed by monocytes (Figure 10C). Moreover, in
the absence of T cells, monocytes did not produce IL-10 upon
iRBC exposure, and TGFb1 levels were unchanged in the
supernatant of purified monocytes co-cultured with either iRBCs
or nRBCs, indicating a need for interaction with T cells to
produce these cytokines (data not shown).
IL-2 is required for Foxp3 induction in general, but only
Foxp3
hi cells specifically require TGFb and IL-10
To test whether TGFb plays a role in the induction of Foxp3
+
CD4 T cells by malaria-infected RBCs, we added TGFb-
neutralizing antibody to the iRBC:PBMC co-culture. Neutralizing
TGFb reduced the proportion of induced CD25
hiFoxp3
hi, but not
CD25
hiFoxp3
int CD4 T cells down to 50.8+/28% (Mean+/
2SEM; P=0.011) (Figure 11A). When assessing the effect of other
blocking Abs, we found that blocking IL-10Ralpha also reduced the
induction of Foxp3
hi cells (P=0.035), but did not affect the
Foxp3
int population. Combined treatment with anti-IL-10Ralpha
and TGFb-neutralizing antibodies in an additional set of 4 donors
further decreased the induction of Foxp3
hi cells compared to anti-
IL-10Ralpha treatment alone (P,0.05) but not compared to anti-
TGFb1,2,3 treatment alone, indicating synergistic action of the two
cytokines but a major role for TGFb compared to IL-10. Blocking
IL-2Ralpha, by contrast, severely inhibited the induction of both
populations (inhibition .98%; P,0.001) consistent with their
induction concomitantly with proliferation, while blocking the pro-
inflammatory cytokine receptors IFNcR1 and IL-6R had no effect
(Figure 11B). Foxp3
hi and Foxp3
int CD4
+CD25
hi T cells were
therefore induced by different mechanisms, requiring distinct
cytokine environments.
Discussion
CD4
+CD25
+Foxp3
+ Tregs were initially thought to mainly play
a role in immune homeostasis to avoid autoimmunity, but are
increasingly also attributed roles in controlling immune responses
to non-self antigens [8], thereby preventing immuno pathology, or
alternatively contributing to immune evasion by tumors or
invading pathogens [45]. An increase in peripheral
CD4
+CD25
+Foxp3
+ T cells has been observed in a number of
infectious diseases including tuberculosis [46,47], hepatitis C [48]
and helminth infections [49,50], as well as human [10–13] and
murine [14–18] malaria infection. Current in vitro models
examining the factors contributing to peripheral induction and
expansion of human or murine CD4
+CD25
+Foxp3
+ T cells
combine strong TCR-stimulation using anti-CD3 mAb, allogeneic
or peptide pulsed APCs together with exogenously added
cytokines IL-2 and TGFb [19,20,51–53].
In this study, we set out to determine whether the above signals
also govern the induction of Foxp3 expression in human CD4 T
cells by malaria-infected RBCs in the absence of any other
exogenous stimuli. We set up an in vitro co-culture system of freshly
isolated human PBMCs and trophozoite-stage iRBCs at a range of
Figure 10. Monocytes and CD4 T cells are the main cellular source of TGFb1 and IL-10 in iRBC:PBMC co-cultures. On day 6 of
iRBC:PBMC co-culture (1:5 ratio), individual cell types were separated by MACS and FACS to subsequently isolate RNA from purified populations.
Relative mRNA levels (normalized on 18SrRNA) for TGFb1 and IL-10 were determined and normalized for each donor on respective levels in total
unseparated PBMC (A). The proportion of individual cell populations expressed as percent of total PBMC was determined by flow cytometry (B).
Relative mRNA levels for IL-10 and TGFb1 for each cell population were corrected for their proportion in whole PBMC by multiplying relative mRNA
levels with the percentage of each population in whole PBMCs for each donor (C). Data (Mean+/2SEM) for 3 donors are shown.
doi:10.1371/journal.ppat.1000543.g010
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This co-culture resulted in the iRBC concentration-dependent
induction of CD4
+CD25
hi IL-10 and TGFb1 mRNA-producing T
cells. These induced CD4
+CD25
hi T cells could be further
subdivided by expression of Foxp3 at either high or intermediate
levels. iRBC-induced CD4
+CD25
hiFoxp3
hi and Foxp3
int T cells
had a phenotype reminiscent of typical CD4
+CD25
+ natural
Tregs, including the expression of immuno-suppressive mediator
molecules such as CTLA-4 or CD39 [23]. In contrast to natural
Tregs, they did, however, also express markers indicating recent
activation. CD4
+CD25
hiFoxp3
hi T cells additionally expressed
higher levels of the Treg markers ICOS and TNFRII compared to
Foxp3
int T cells. In line with this, Walther and co-workers recently
also found a correlation between Foxp3 and TNFRII levels on
Tregs from malaria infected children [13], and Minigo and
colleagues reported higher levels of TNFRII expression on Tregs
from individuals with severe as opposed to uncomplicated malaria
[12]. Out of the parasite-induced CD25
hi CD4 T cells, the Foxp3
hi
population was practically devoid of pro-inflammatory cytokine
producing cells consistent with a T regulatory phenotype. In
contrast, the Foxp3
int population contained significant subsets of
cells producing the major Th effector cytokines IFNc (Th1), IL-4
(Th2), IL-17 (Th17) as well as the T cell growth factor IL-2
consistent with an effector phenotype. The predominant cytokine
produced by the Foxp3
int subset was the Th1 cytokine IFNc,
consistent with a recent study by Walther and co-workers [13].
Moreover, we found a significant inverse correlation between
Foxp3
hi:Foxp3
int ratios and the percentage of IFNc, IL-4 and IL-
17 producing cells within the Foxp3
int population, indicating
suppressive activity of parasite-induced Foxp3
hi cells on Th
effector cytokine production by parasite-induced effector Foxp3
int
cells. Interestingly and in line with our findings, Treg frequencies
Figure 11. Differential role of TGFb, IL-10 and IL-2 for the induction of Foxp3
hi and Foxp3
int T cells. The influence of neutralizing anti-
TGFb1,2,3 (100 mg/ml) and anti-IL-10Ralpha (50 mg/ml) alone or in combination (A), and receptor-blocking Abs for IL-2Ralpha (50 mg/ml), IFNcR1 (50 mg/
ml) and IL-6R (5 mg/ml) (B) on the induction of Foxp3
hi and Foxp3
int CD4
+CD25
hi T cells was determined by flow cytometry after 6 days of iRBC:PBMC
co-culture. Each graph shows data for 4–6 donors (Mean+/2SEM) as fold changes in the proportion of CD25
hiFoxp3
hi or CD25
hiFoxp3
int cells from
total CD4 T cells. Fold changes were calculated by normalizing for each donor the percentage of each of the two cell types of CD4
+ T cells in
blocking/neutralizing Ab-treated cultures (black bars) on the respective percentage of CD4
+ T cells obtained for isotype control-treated iRBC:PBMC
co-cultures (white bars).
doi:10.1371/journal.ppat.1000543.g011
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negatively correlate with the magnitude of malaria-specific
memory IFNc responses in human malaria patients [13].
Moreover, an ethnic group in West Africa, the Fulani, shows a
functional deficit in Treg related gene expression [54], as well as
elevated levels of peripheral blood malaria-specific Th1 (IFNc) and
Th2 (IL-4) producing cells [55].
The majority of both CD4
+CD25
hiFoxp3
hi and Foxp3
int T cells
had proliferated and were also induced in iRBC:PBMC cultures
previously depleted of natural CD4
+CD25
+ Tregs, strongly
suggesting their main origin in the CD4
+CD25
2 naı ¨ve T cell
population, with an additional and independent contribution from
natural Tregs to the parasite-induced generation of CD4
+CD25
hi-
Foxp3
hi T cells. Future studies may further explore the potentially
different functional properties or alternative pathways of genera-
tion of the subset of Foxp3
+ T cells that failed to proliferate by day
6 of co-culture. Monocytes expressing increased levels of co-
stimulatory molecules as well as IL-10 and TGFb mRNA were
sufficient for iRBC-induced Foxp3 expression in purified T cells.
Importantly we demonstrate here for the first time, to our best
knowledge, that direct TCR stimulation is not strictly required for
Foxp3 induction in CD4 T cells by an infectious agent. The
induction of Foxp3 expression occurred in transwell-separated
responder/bystander T cells solely responding to soluble factors
without their direct interaction with monocytes. The 20 nm pore
size of the transwell inserts also eliminates the possibility that
monocyte derived MHC class II-bearing exosomes, which are 50–
100 nm in diameter, could have transferred antigen between the
two chambers [56,57]. A final possibility would be TCR
stimulation resulting from direct T cell-to-T cell presentation of
iRBC-derived peptides, possibly acquired from APC-derived
soluble MHC as reported for CD8
+ T cells [58]. This possibility
can, however, also be excluded as Foxp3 induction did neither
occur when T cells were directly cultured with iRBCs, nor when T
cells were separated from iRBC-exposed monocytes, as a potential
source of such peptides, through a transwell. Instead, monocyte/
MHC class II interaction with helper CD4 T cells was critical to
initiate the secretion of the soluble mediators IL-2 and IL-10,
which were necessary for the induction of Foxp3
hi expression in
transwell-separated bystander CD4
+ T cells (Figure 12). The
generally lower levels of either Foxp3
int or Foxp3
hi T cells outside
the transwell (compared to directly cultured cells) can at least
partially be explained by the consumption of cytokines as well as
other potential soluble mediators by CD4 T cells inside the
transwell insert, converting into Foxp3
+ cells themselves. While we
cannot exclude that soluble factors derived from TCR-stimulated
T cells inside the transwell might additionally act in an autocrine
fashion in concert with TCR-stimulation in these cells, this was
clearly not the case for their counterparts outside the transwell.
These findings contrast the common assumption that peripheral
induction of Foxp3 expression in CD4
+CD25
2 T cells necessarily
requires stimulation through the TCR [20]. While it has been
shown that the foxp3 gene has response elements that can positively
regulate the trans activation of the foxp3 promoter after triggering
Figure 12. Proposed model of Foxp3 induction by malaria-infected RBCs. Upon exposure to malaria-infected RBCs, monocytes interact with
CD4
+ T cells via MHC class II (1), which induces IL-2 and IL-10 secretion from these cells (2). IL-2 contributes to the conversion of CD4
+CD25
2 into
CD25
hiFoxp3
int cells (3). Additionally, CD4
+ T cell-derived IL-2 in conjunction with monocyte and T cell-derived IL-10 and TGFb acts on bystander
CD4
+CD25
2 T cells as well as CD4
+CD25
+ nTregs, that have not interacted with monocytes and therefore received no signal through their TCR
themselves (4). This drives/enhances Foxp3 expression in these cells, resulting in the generation of CD25
hiFoxp3
hi CD4 T cells (5). These CD25
hiFoxp3
hi
CD4 T cells in turn regulate the production of the Th effector cytokines IFNc, IL-4 and IL-17 by parasite-induced CD25
hiFoxp3
int CD4 T cells (6).
doi:10.1371/journal.ppat.1000543.g012
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according to our data, is not an absolute requirement. The fact
that the induction of Foxp3 expression in CD4
+ T cells does not
require direct contact of these cells with APCs such as monocytes
via the TCR also implies that there is no mechanism to ensure that
induction of Foxp3 expression is confined to T cells specific for the
same antigen, as proposed elsewhere [20]. This in turn may
explain why immune suppression during acute malaria infection,
for instance, is not confined to T cell responses against malarial
antigens, but also other pathogens such as Epstein Barr virus
[5,62], Herpes Zoster virus [3] or Salmonella species [6] as well as
vaccine antigens administered during and after acute malaria
infections [4,7].
CD25
hiFoxp3
hi and CD25
hiFoxp3
int cells generated outside the
transwell without direct monocyte contact did further display
similar functional characteristics compared to those induced in
direct co-cultures, and similar expression levels of CD127, CD39
and CD45RO compared to day 0 CD25
+Foxp3
+ nTreg and day 6
Foxp3
hi and Foxp3
int cells in direct co-cultures. However, while
TNFRII, ICOS and CTLA-4 expression was higher in Foxp3
hi
compared to Foxp3
int cells in both direct and transwell-separated
cultures, overall expression levels of these markers were markedly
lower in Foxp3 expressing T cells induced in transwell-separated
cultures, indicating that high levels of expression of these
molecules do require direct TCR or co-stimulation of these cells.
In fact all three molecules are known to be up-regulated upon
TCR stimulation, and CD80/CD86-mediated CD28 co-stimula-
tion of T cells further increases CTLA-4 expression and is required
for ICOS expression [63–66]. Thus, while Foxp3
hi with a Treg
phenotype and functional capacity, and to a lesser extend also
effector-like Foxp3
int cells, can be induced across the transwell by
soluble factors in a TCR independent manner, it is likely from
these data that in direct co-cultures these cells do in fact receive a
TCR/co-stimulatory signal that enhances expression levels of
some, but not all surface markers including TNFRII and ICOS as
well as intracellular CTLA-4.
Foxp3
hi:Foxp3
int ratios were higher in transwell separated T
cells, most likely due to the stagnation of Foxp3
int levels but a
further increase in Foxp3
hi levels from day 4 onwards. This
suggests that the induction/expansion of Foxp3
int cells may be
more reliant on cell-to-cell contact, while Foxp3
hi CD4
+ T cells
may be more easily induced and expanded by soluble factors in the
co-culture system. Specifically, we found that both populations
critically relied on monocyte/MHC class II-induced IL-2, which is
consistent with the multiple roles of IL-2 in regulatory and
inflammatory T cell responses [67]. However, only CD25
hiFox-
p3
hi CD4 T cells, which were detectable 24 later than
CD25
hiFoxp3
int cells, were also dependent on TGFb1 and IL-
10. Interestingly, IL-10 and TGFb secreted by natural or induced
Treg have been reported to convert naive CD4 T cells into Foxp3
expressing Tregs [68]. The importance of these two cytokines for
the induction of CD4
+CD25
hiFoxp3
hi T cells may explain
previous findings showing an association between IL-10 and
TGFb production early during malaria infection and an increase
in CD4
+CD25
+(Foxp3
+) T cells [11,12,28]. Further, CD4
+ T cells,
and specifically those in the CD25
hi fraction, were the major
cellular source of these two cytokines in iRBC-co-cultured
PBMCs. In this context it was recently shown that effector T
cells co-producing IFNc and IL-10, which are more prevalent in
children with mild than severe malaria, may help to regulate acute
malarial inflammation [13]. It is therefore a possibility that the
more contact-dependent CD4
+CD25
hiFoxp3
int T cells constitute
the above mentioned TCR-stimulated, cytokine secreting helper T
cells (which via IL-2, IL-10 and potentially TGFb secretion
subsequently act on responder/bystander T cells), thereby further
promoting TCR-independent induction of CD4
+CD25
hiFoxp3
hi
T cells (summarized in Figure 12). Future studies using this in vitro
iRBC:PBMC co-culture system can further investigate the
potential roles of mediators other than MHC class II stimulation
and TCR stimulation or the above cytokines in the induction of
Foxp3 expression.
Besides CD4
+CD25
hi T cells, monocytes in iRBC:PBMC
cultures were a major source of the immuno modulatory cytokines
IL-10 and TGFb1 in our study. This is in accordance with an
earlier study on Treg induction in experimental malaria infection
of healthy UK volunteers, which identified monocytes as the
predominant source of early serum TGFb [11]. IL-10 production
has equally been attributed to iRBC-exposed APCs [69–72].
Interestingly, however, we found no detectable IL-10 in the
supernatant of purified monocytes co-cultured with iRBCs in the
absence of, or transwell-separated from T cells, and there was also
no difference in supernatant TGFb levels between purified
monocytes co-cultured with iRBCs or nRBCs (data not shown).
This indicates that contact with T cells may be required for
monocytes to produce these cytokines in response to iRBC
exposure, and future studies are needed to further explore the
interplay and potential reciprocal modulation between the two cell
types.
iRBC-exposed monocytes also up-regulated expression of co-
stimulatory molecules, which for CD80 and CD86 was dependent
on the parasite dose. In pregnancy-associated malaria, iRBCs
preferentially accumulate in the placenta leading to higher parasite
exposure of placental compared to peripheral blood monocytes
[73], and CD80 and CD86 expression was higher in placental
compared to peripheral monocytes [74]. The contribution of
diverse parasite factors and their corresponding receptors on
monocytes to monocyte activation and subsequent induction of
Foxp3 expression will be an important subject of future studies and
may involve molecules such as TLR9 [75] and the scavenger
receptor CD36 [76–78]. The induction of Foxp3 expression in
CD4
+ T cells by APCs expressing the co-stimulatory molecules
CD80 and CD86 is consistent with previous reports [53,79].
CTLA-4 ligation via CD80 shortly after T cell activation is
necessary to enable TGFb-induced Foxp3 expression [80], and co-
stimulation via CD28 has been shown to mediate survival of
murine Tregs induced by TCR/TGFb1-stimulation [81]. Bane-
rjee and co-workers further demonstrated that APCs are most
effective in inducing functional Foxp3
+CD4
+ T cells when treated
with pro-inflammatory cytokines TNF, IL-6 and IL-1b [79], all of
which were detectable in the iRBC:PBMC co-cultures used in this
study. Importantly, co-stimulation by APCs has been found to be
necessary to induce T cell-derived IL-2, which is crucial for the
induction of Foxp3 expression [44,53] and consistent with the
findings presented here. IL-2 does not, however, directly induce
Foxp3, but is essential for TGFb1 induced Foxp3 expression in
CD4
+CD25
2 T cells as well as their expansion [51]. Furthermore,
IL-2 signaling via STAT5 through the IL-2Rb chain (CD122),
which is expressed by both Foxp3
hi and Foxp3
int CD4
+CD25
hi T
cells in this study, has been shown to be crucial for Foxp3
expression and Treg function [82,83].
The fact that Foxp3 induction also occurred in iRBC:PBMC
cultures previously depleted of natural CD4
+CD25
+ Tregs is
consistent with the origin of future Foxp3
+ cells in the
CD4
+CD25
2 naı ¨ve T cell population and supported by other
studies describing this phenomenon [53,84–86]. IL-2 dependent
induction of Foxp3 in this population devoid of IL-2 receptor
expression can be explained by the coordinated induction of
CD25 by the parasite cytokine environment: IL-6, TNFa and
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[66,84–89], and IL-2 itself has been shown to promote gene
expression of its own receptor [90] even in human CD25 depleted
PBMC, i.e. in the absence of IL-2 receptor expression, on both
CD4
+ and CD8
+ T cells in the absence of antigenic stimulation
[91]. Thus, cytokines including TGFb and IL-2 as well as
potential parasite-derived factors in iRBC:PBMC co-cultures
m a yi n d u c eC D 2 5e x p r e s s i o ni nn a ı ¨ve CD4
+CD25
2 T cells,
rendering these cells responsive to IL-2, resulting subsequently in
enhanced CD25 expression, IL-2 promoted Foxp3 induction and
proliferation.
Decreased TGFb1 levels in the co-culture supernatants are
consistent with increased consumption of TGFb and were evident
as early as 24 hours after addition of iRBCs to PBMCs. The
importance of early TGFb exposure for Foxp3 induction has been
shown in vitro [52] and in experimentally malaria-infected human
volunteers [11]. Furthermore, it has been observed that Treg-
derived surface TGFb or TGFb bound to latency associated
peptide on the surface of induced Tregs [20] or immature DCs
[92] can in turn induce Foxp3 expression in responder cells. The
Fulani, an ethnic group in West Africa with a decreased
susceptibility to P. falciparum malaria, have a deficit not only in
Foxp3 but also TGFb, TGFbR mRNA expression in CD4
+CD25
+
Tregs and lower serum TGFb levels [54]. This raises the question
whether insufficient TGFb availability might contribute to the
deficit in Foxp3 in these cells and hence the more potent anti-
malarial immune responses in this population.
In summary, we examined and defined the contribution of host
immune mechanisms including APC-mediated TCR stimulation
and cytokines to the induction of Foxp3 expression by the malaria
parasite. Using an in vitro co-culture system of purified parasitized
RBCs and PBMCs in the absence of any artificial exogenous
stimuli, we have demonstrated the in vitro generation of two distinct
populations of effector-like Foxp3
int and regulatory cell-like
Foxp3
hi CD4
+CD25
hi T cells. Our co-culture system may well
reflect the processes occurring in vivo during malaria-infection, and
explain the elevated levels of CD4
+CD25
hiFoxp3
+ T cells observed
in malaria-infected individuals and the association of IL-10, TGFb
and IL-2 with their induction. The induction of these cells even in
the absence of direct contact of monocytes with converting T cells
implies that peripheral induction of CD4
+CD25
+Foxp3
+ cells is, in
contrast to current belief, not necessarily linked to direct antigen-
specific TCR stimulation. Future studies are now required to
determine whether other pathogens are also able to induce such
cells without the need for direct and concomitant TCR
stimulation.
Materials and Methods
P. falciparum culture and trophozoite isolation
Mycoplasma-free blood-stage parasites of Plasmodium falciparum
(strain 3D7) were maintained in O
+ erythrocytes in RPMI-1640
medium (JRH, Lenexa, KS, USA) supplemented with 1 mM
glutamine, 11 mM glucose, 25 mM HEPES, 0.2% (w/v) sodium
bicarbonate, 200 mM hypoxanthine, 40 mg/ml gentamycin (all
Sigma-Aldrich, St. Louis, MO, USA), and 0.5% (w/v) AlbuMAX
II (GIBCO, Invitrogen, Carlsbad, CA, USA) at 37uCi na n
atmosphere of 5% CO2 and 1% O2 in N2. Knob-expressing
parasites were enriched weekly using gelofusine solution (Braun
Melsungen, Germany). Trophozoite stage parasites were isolated
by density gradient centrifugation following layering onto a
gradient of 40/60/80% isotonic Percoll (Amersham Biosciences,
Uppsala, Sweden). The percentage of infected erythrocytes was
typically 90–100%.
PBMC isolation and iRBC:PBMC co-culture
PBMCs were recovered by Ficoll–Hypaque (Amersham Biosci-
ences) density gradient centrifugation from buffy coats (Australian
Red Cross Blood Service, Melbourne, Australia). Autologous
human serum (HS) was obtained by coagulating platelet-rich
plasma from buffy coats with 0.3% (w/v) CaCl2, followed by heat-
inactivation at 56uC for 30 min. PBMCs were cultured in AIM-V
medium (GIBCO, Invitrogen) supplemented with 5% autologous
HS alone (untreated controls), with non-infected control erythro-
cytes or trophozoite-stage iRBCs. iRBC:PBMC ratios were
calculated to reflect parasitemia ranges in natural infections (2:1
ratio ,0.1% parasitemia or 5000 iRBC/ml blood; 1:5 ratio
,0.01%; 1:50 ratio ,0.001%), assuming an average RBC count
of 6610
6/ml blood and 3610
3 PBMCs/ml blood (white blood cell
count minus granulocytes). In some experiments, tissue culture
inserts (Anopore, NUNC, Naperville, IL, USA) were used to
separate iRBC-treated (inside) and untreated cell populations
(outside the transwell). A pore size of 20 nm was chosen to prohibit
transfer of hemozoin crystals, which are on all sides larger than this
cut-off [93].
Magnetic cell isolation and add-back experiments
PBMCs were separated using the Pan-T cell negative isolation
kit and CD14 microbeads (Miltenyi Biotech, Bergisch Gladbach,
Germany) according to the manufacturer’s recommendations in
combination with LS (negative selection), MS (positive selection)
and LD (depletion) columns. T cells and monocytes were typically
.97% pure. CD14
+ monocytes were added back to purified T
cells based on original donor-specific ratios as determined by flow
cytometry analysis for each donor. CD3
+ T cells ranged from 45–
57% and CD14
+ monocytes from 7–31% of total PBMCs. For
some experiments, PBMCs were depleted of CD25
+ cells using
anti-CD25 PE antibody (BD Pharmingen) and anti-PE microbe-
ads (Miltenyi Biotech).
Cell phenotyping by flow cytometry and intracellular
cytokine staining
Anti-CCR7 PE was purchased from R&D systems (Minneapo-
lis, MN, USA), and anti-CD39 PE was from Serotec (Oxford,
UK). Anti-Foxp3 (clone PCH101) and anti-IL-17A PE were
obtained from eBiosciences (San Diego, CA, USA) and anti-Foxp3
(clone 259D) was from Biolegend (San Diego, CA, USA). Anti-IL-
2 APC was from Miltenyi Biotech. All other fluorochrome-
conjugated monoclonal antibodies and isotype controls were
purchased from BD Pharmingen (San Jose, CA, USA). For
intracellular cytokine staining, cells were re-stimulated on day 6 of
iRBC:PBMC co-culture for 5 hours with phorbol 12-myristate 13-
acetate (PMA) (50 ng/ml) and ionomycin (1 mg/ml) (both Sigma)
in the presence of brefeldin A (eBioscience) for the last 4 hours.
Cells were washed with PBS and incubated with antibodies diluted
in PBS/10% HS/0.01% NaN3 (sodium azide) for 30 min on ice.
Intracellular staining for Foxp3, CTLA-4 and cytokines was
performed using the eBioscience fixation/permeabilization buffer
kit. A minimum of 10
5 events in the lymphocyte gate was acquired
using a FACScalibur flow cytometer for 4-colour analysis and on a
FACSAria for 5 to 6-colour analysis, and analyzed using
WEASEL software (WEHI, Melbourne, Australia). Cells were
gated first based on forward and side scatter to excluded dead cells
and cell debris. Cells in the lymphocyte gate were then further
gated based on forward scatter (to exclude monocytes) versus CD4
expression. Whenever possible, a CD3 stain was included as well
to ensure that gated CD4
+ cells were indeed T cells. Phenotyping
of monocytes was carried out by gating on CD14
+ cells that were
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histograms and dot plots are depicted in log scale.
CFSE proliferation
CFSE labeling was employed to distinguish between dividing
and non-dividing cells [94]. Freshly isolated PBMCs were re-
suspended at 10
6cells/ml in PBS/0.1% FCS and incubated with
0.4 mM CFSE (Molecular Probes, Invitrogen) for 5 minutes at
37uC before staining was quenched with ice-cold RPMI/10%
FCS. Cells were washed and set up as described above.
Inhibition assays with anti-MHC class II and cytokine
receptors-blocking antibodies
To examine the effect of cytokines, PBMCs were pre-incubated
for 1 h at 37uC with blocking antibodies directed against human
IFNcR1 (mIgG1, clone 92101), IL-2Ralpha (mIgG1, clone 22722),
IL-6R (polyclonal goat IgG), IL-10Ralpha (mIgG1, clone 37607) or
TGFb1,2,3 (mIgG1, clone 1D11) (all R&D Systems). MHC class II
dependency was determined using anti-HLA DR mAb (mIgG2a,
clone L243; BD Pharmingen). Normal goat IgG, mIgG1 or
mIgG2a were used as isotype controls. All antibodies were sodium
azide free. iRBC-PBMC co-cultures for each donor were set up in
triplicate.
Assays for cytokines
Supernatants were collected at indicated time points and stored
at 220uC until assayed in duplicate for cytokines using Cytokine
ELISA OptEIA kits (BD Pharmingen) according to the manufac-
turer’s recommendations.
RNA extraction and quantitative real-time RT-PCR
analysis
Total RNA was isolated from a minimum of 10
5 iRBC-
stimulated total PBMCs or MACS-sorted CD4
+CD25
2 and
CD4
+CD25
hi T cells using the RNeasy kit (Qiagen, Hilden,
Germany) according to the manufacturer’s recommendations.
cDNA was synthesized using multiscribe reverse transcriptase and
random hexamer primers in the presence of RNase inhibitor
(Applied Biosystems, Foster City, CA) at 42uC for 15 min,
followed by 5 min at 99uC. Foxp3, IL-10, TGFb and
18SrRNA-specific primers and TaqMan probes were designed
using Primer Express software (Applied Biosystems) and synthe-
sized by Geneworks (primers) and Applied Biosystems (probes)
(Table 1). Quantitative real-time PCR was performed in duplicate
on an ABI PRISM 7900 (Applied Biosystems) as follows: 50uC for
2 min, 95uC for 10 min followed by 40 cycles of 95uC for 15 s and
60uC for 1 min. Results for target genes were normalized to
18SrRNA expression and expressed as fold changes between the
cell populations of interest.
Data presentation and statistical analysis
In most graphs depicted in this manuscript, we employed
normalization onto control conditions for each donor, to be able to
analyze changes in Foxp3
hi or Foxp3
int proportions (measured as
percentage of CD4 T cells), surface marker expression levels
(measured as median fluorescence intensity (MFI) or percent
positive cells) or cytokine levels (measured in pg/ml) independent
of variation of absolute values between different human donors.
Normalized values are referred to as fold change compared to
control conditions. To allow immediate identification, control
conditions onto which other data in an experiment were
normalized for each donor (value 1) are depicted as white bars,
as opposed to black bars for all other conditions throughout.
Statistical analysis was carried out using GraphPad Prism software
v4 (San Diego, CA, USA). P values were determined by either
Wilcoxon’s signed rank test for absolute values, or two-tailed
paired Student’s t-test for normalized values. Three or more
groups were compared by repeated-measures one-way ANOVA,
followed by the linear trend, Dunnett’s or Neuman-Keuls’
multiple comparison post test. Correlation analysis was performed
using Spearman rank correlation. A P value,0.05 was considered
significant.
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